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Collagen synthesisrespond to injury with a coordinated set of events (termed activation), which
includes migration and upregulation of matrix protein production. Cell migration requires an intact actin
cytoskeleton that is linked to the plasma membrane by ezrin–radixin–moesin (ERM) proteins. We have
previously found that the linker protein in HSCs is exclusively moesin. Here, we describe HSC migration
and ﬁbrogenesis in moesin-deﬁcient mice. We developed an acute liver injury model that involved focal
thermal denaturation and common bile duct ligation. HSC migration and collagen deposition were assessed
by immunohistology and quantitative real-time PCR. Activated HSCs were isolated from wild-type or
moesin-deﬁcient mice for direct examination of migration. Activated HSCs from wild-type mice were
positive for moesin. Migration of moesin-deﬁcient HSCs was signiﬁcantly reduced. In a culture assay, 22.1%
of normal HSCs migrated across a ﬁlter in 36h. In contrast, only 1.3% of activated moesin-deﬁcient HSCs
migrated. Collagen deposition around the injury area similarly was reduced in moesin-deﬁcient liver. The
linker protein moesin is essential for HSC activation and migration in response to injury. Fibrogenesis is
coupled to migration and reduced in moesin-deﬁcient mice. Agents that target moesin may be beneﬁcial
for chronic progressive ﬁbrosis.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The response to liver injury is multi-faceted, involving several
cell types and elaboration of a collagen-rich extracellular neomatrix,
which serves both to strengthen the tissue and as a scaffolding upon
which repair events proceed. Over time, the neomatrix undergoes
chemical changes that render it resistant to degradation. Hence, the
interest in strategies to modulate ﬁbrogenesis. Hepatic stellate cells
(HSCs) are prominent in the repair response as the principal sourceadixin–moesin; Msn, moesin;
1, transforming growth factor
erase chain reaction
ion of Digestive Surgery, Kyoto
yo-ku, Kyoto 602-8566, Japan.
hi).
ll rights reserved.of extracellular matrix. They are also motile and migrate to the
injury site. Migration appears to be among the initial responses to
injury. The chemoattractant for HSC migration and intracellular
signaling pathways has been deﬁned [1]. The cells appear to utilize
a pathway that consists of hyaluronic acid and CD44, a cognate
receptor for this matrix constituent [2]. Migration also requires
mechanical force generation, which is mediated by the actin
cytoskeleton. The latter structure comprises actin linked to the
plasma membrane by a protein of the ezrin–radixin–moesin (ERM)
family, which forms a complex with a variety of other membrane-
associated proteins [3–6].
The ERM components in HSCs have not been deﬁned, nor have
their role in cell migration after acute injury. Many ﬁbroblastic cells
contain more than one ERM protein. We showed that HSCs, in
contrast, contain only moesin. We studied migration and activation
of HSCs with or without moesin, after an injury challenge. HSCs from
mice lacking moesin displayed signiﬁcantly impaired migration and
activation relative to those in wild-type cells. Fibrogenesis was
decreased in parallel.
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2.1. Animals
We have previously generated moesin-deﬁcient (Msn−/−) mice on a
mixed genetic background (129/Sv × C57BL/6J) [7]. The mice were
back-crossed through more than eight generations to create congenic
C57BL/6JMsn−/− mice. All experiments were carried out in accordance
with guidelines established by the Guidelines for Animal Experiments
of Kyoto Prefectural University of Medicine, Kyoto, Japan.
2.2. Antibodies and reagents
Rabbit polyclonal antibodies (TK89, anti-mouse ERM) and mono-
clonal antibodies (M11, anti-mouse ezrin; R21, anti-mouse radixin;
M22, anti-mouse moesin) were provided by the Department of Cell
Biology, Faculty of Medicine, Kyoto University, Japan [8]. Anti-α-
smoothmuscle actin (SMA)/FITC-conjugatedmonoclonal antibodywas
purchased from Sigma–Aldrich (St. Louis, MO, USA). Alexa Fluor 546-
conjugated secondary antibody was used (Invitrogen, Molecular
Probes). Sevoﬂurane (Sevofrane®) for anesthesia was from Abbott
(Chicago, IL, USA). Collagenwas visualizedwith 0.1% Sirius Red solution
(Polysciences, Warrington, PA, USA) saturated in picric acid solution
(Wako, Tokyo, Japan). Collagenase was from Nacalai Tesque (Tokyo,
Japan), pronase and DNase from Roche (Basel, Switzerland), and Opti
prep® fromAxis-Shield PoCAS (Oslo, Norway). Ham's NutrientMixture
F12 and Dulbecco's Modiﬁed Eagle's Medium (DMEM) were from
Nissui Pharmaceutical (Tokyo, Japan) andASF104 culturemedium from
Ajinomoto (Tokyo, Japan). Cell culture inserts were pre-coated with
hyaluronic acid (sodium salt, 1mg/ml) from Streptococcus equi
(BioChemica, Melbourne, FL, USA) before the migration assay.
2.3. Surgical procedures
2.3.1. Biliary obstruction model by common bile duct ligation
For studies of liver ﬁbrosis and HSC activation in vivo, the common
bile ductwas ligated. Seven days later, themicewere sacriﬁced to isolateFig. 1. Periductal ﬁbrosis by common bile duct ligation. Collagenwas stained using Sirius red (
(A and B); Msn−/− mice (C and D). Bile duct proliferation and periductal collagen deposit
proliferation were signiﬁcantly reduced (C and D). Original magniﬁcation, ×200. Asterisk, bHSCs for liver perfusion, as described previously [2]. For histological
examination, the mice were sacriﬁced on 7 and 14 days after operation.
2.3.2. Hepatic injury model by thermal denaturation
The injury device was an electrically heated probe with a beveled
tip of 2mm diameter, which was set at 150 °C (Taiyo Electric,
Hiroshima, Japan). A 1-s application of the tip to the surface of the
liver reproducibly resulted in a hemispheric injury of 3 mm diameter.
Two lesions were created in the left lobe and one in the right lobe.
Mice were sacriﬁced after 1 or 2 weeks, with removal of the whole
liver, including the adherent peritoneal wall (including parietal
peritoneum and muscle). The reason for this procedure was to
remove completely and keep the fragile injured liver surface. Each
experimental group consisted of 4–6 mice.
2.4. Histology and immunoﬂuorescent microscopy
For in situ histology, the liver was perfused sequentially with PBS
(pH 7.4) and 4% phosphate-buffered formaldehyde. Tissue sections
(5μm) were treated with xylene, and rehydrated with decreasing
graded ethanol. Hematoxylin stain and Sirius Red stain were
performed for histological analysis and collagen visualization,
respectively. For immunoﬂuorescent staining of normal or bile
duct ligation (BDL) mouse livers, the liver was removed from Msn+/+
and Msn−/− mice, cut into small pieces, and frozen in liquid nitrogen.
Frozen sections were cut on a cryostat, mounted onto cover glasses,
air dried, and ﬁxed with 95% ethanol for 15 min at 4 °C, followed by
100% acetone for 1min at room temperature. A pair of frozen
sections from the Msn+/+ and Msn−/− liver was placed on the same
cover glass and processed for double staining with the appropriate
antibodies. The images were obtained with a ﬂuorescence micro-
scopy (model IX71; Olympus, Tokyo, Japan) and DP Manager
(Olympus). In vivo-activated HSCs were cultured for 2days, and
then treated with rat anti-ERM monoclonal antibody (M11, anti-
mouse ezrin; R21, anti-mouse radixin; M22, anti-mouse moesin).
Secondary antibodies were conjugates of Alexa Fluor 546 (Molecular
Probes). FITC-conjugated anti-α-SMA was used for double staining.red stain) 7 (A and C) and 14 (B and D) days after common bile duct ligation.Msn+/+mice
ion were dominant in Msn+/+ mice (A and B). In Msn−/− mice, collagen synthesis and
ile duct.
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TritonX-100 avoiding autoﬂuorescence for plenty of retinoids.
2.5. One-step real-time RT-PCR
Total RNA was extracted from whole liver with RNeasy kits
(QIAGEN, Hilden, Germany). One-step real-time RT-PCR was per-Fig. 2. Moesin deﬁciency reduced collagen synthesis in liver injury induced by heat caute
created in each mouse liver (white arrow). The area of necrosis was ∼3 mm. (D) The injury
injury. HSCs are seen accumulating in Msn+/+ mouse liver. Necrotic tissue was absorbed and
E and F) Collagen was stained using Sirius Red (red stain) 14 days after focal thermal denatu
the periphery of the injury (black arrow) in Msn+/+ mice. In Msn−/− mice, collagen deposition
The amount of Sirius Red-positive tissues of focal thermal denaturation was determined as a
(Msn−/−). ⁎Pb0.0001.formed using Quantitect™ SYBR Green RT-PCR kit (QIAGEN) and Light
Cycler 1.5 (Roche, Mannheim, Germany). Primers were designed by
Primer Express Software (PE Applied Biosciences, CA, USA). For all
primer pairs, speciﬁcity was conﬁrmed by sequencing PCR products.
Target gene levels are presented as a ratio of levels in BDL versus
sham-operated groups (control), according to the ΔΔCt method.
The primers used were as follows: GUS (NM_010368): forward,rization. (A) Acute hepatic injury using a heated probe. Three individual lesions were
focus (black arrow) showed an inﬂammatory inﬁltrate and angiogenesis on day 7 after
replaced by ﬁbrous tissue. Hematoxylin–eosin stain. Original magniﬁcation ×100. (B, C,
ration. Msn+/+ mice (B and C); Msn−/− mice (E and F). Collagen ﬁbers were abundant at
was signiﬁcantly reduced. Original magniﬁcation, ×100 (B and E), ×200 (C and F). (G)
percentage of section volume (VFib). The values were 39.3±5.2% (Msn+/+) and 11.4±3.4%
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αSMA (NM_007392): forward, AAACAGGAATACGACGAAG; reverse,
CAGGAATGATTTGGAAAGGA: TGFb1 (NM_011577):NM_011577 for-
ward, TTGCCCTCTACAACCAACACAA; reverse, GGCTTGCGACCCACG-
TAGTA; procollagen Iα1NM_007742 (NM_007742): forward,
GACATCCCTGAAGTCAGCTGC; reverse, TCCCTTGGGTCCCTCGAC; pro-
collagen Iα2 (NM_007743): forward, CTCCAAGGAAATGGCAACTCAG;
reverse, TCCTCATCCAGGTACGCAATG [9].
2.6. Immunoblotting
The liver was taken fromMsn+/+ andMsn−/−mice and homogenized
in SDS sample buffer (50mMTris–HCl, pH 6.8, 2% SDS, 20% glycerol, 2%
2-mercaptoethanol and 0.01% bromophenol blue). Total lysate (20 μg)
was separated by SDS-PAGE, and electrophoretically transferred from
gels to PVDF membranes for immunoblotting. Immune complexes
were detected using horseradish-conjugated goat anti-rabbit IgG
fragments (dilution, 1:1000; DakoJapan, Tokyo, Japan) and the ECL
Western blotting detection system (Amersham, Bucks, UK). We
quantiﬁed the individual immunoblotted bands by comparing their
intensities with those of serially-diluted reference standards for ﬁve
separate combinations of Msn+/+ and Msn−/− mice.
2.7. Image analysis
Image analysis for ﬁbrosis was performed with Image J (National
Institutes of Health, Bethesda, MD, USA) by three people blinded to theFig. 3. Quantitative analysis of HSC activation and ﬁbrosis in Msn+/+ and Msn−/− mouse l
quantitative real-time PCR of total liver RNA obtained after 7 and 14 days of BDL or sham op
operation) mice. Expression of α-SMA, TGFβ-1 and procollagen α1/2(I) was signiﬁcantly
experimental group consisted of control (n=3) and treated (n=5) mice. Data expressed as mexperimental protocol. The same background thresholdwas used in all
specimens to distinguish black and white. Then, the amount of black
and white was analyzed, and the percentage of white was recorded as
theﬁbrosis volume (VFib), whichwas represented bySirius red-positive
tissue.
2.8. HSC isolation
Invivo-activatedHSCswere isolated fromcommon-bile-duct-ligated
Msn+/+ and Msn−/− mice 7days after operation. The liver was perfused
with PBS that contained 100 IU/ml heparin (30 ml/h, 5min), 0.025%
pronase (80 ml/h, 30 min), and 10.7 IU/ml collagenase (140ml/h,
30min). At the end of the perfusion period, the liver was removed and
stirred with 0.001% DNase (37 °C, 30 min). HSCs were isolated on an
11.5% OptiPrep® density gradient. The purity of isolated HSCs was
assessed as the percentage of cells that exhibited transient blue
ﬂuorescence under UV excitation. The average yield per liver was 1.0 ×
106 cellswith purity of 70–90%. The cellswere plated in 20% FBS/DMEM.
2.9. HSC migration assay
Culture inserts were pre-coated with hyaluronic acid (1mg/ml),
then rinsed with PBS before use. Isolated HSCs (1 × 103 cells/each cell
culture insert) were plated in DMEM with 20% FBS. After 12 h, cell
culture inserts were transferred to 24-well cluster plates in serum-free
ASF 104 medium for the migration assay, as described previously. At
the indicated times of migration, membranes were removed from theiver. mRNA levels of procollagen α2/α2(I), α-SMA and TGFβ-1 were determined by
eration. Results were normalized to β-glucuronidase (GUS) expression in control (sham
reduced in Msn−/− mouse liver at 7 and 14 days after BDL. ⁎Pb0.05, ⁎⁎Pb0.01. Each
ean±SD data.
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stained with hematoxylin. Migration was scored as the number of
HSCs on the bottom of the membrane (Lw) and the top surface of
membrane (Up), in the same ﬁelds at 400× magniﬁcation; each ﬁeld
contained about 10 cells, and 20 ﬁelds were assessed for each study.
The migration index was (Lw/Up + Lw = %). Each experimental group
consisted of ﬁve mice.
2.10. Statistical analysis
Results are expressed as means ± SD. Signiﬁcance was established
using Student's t test and analysis of variance. Differences were
considered signiﬁcant at P b 0.05. The data were analyzed by Graph
Pad Prism5 (GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Wound healing and liver ﬁbrosis
Common bile duct ligation raises cholestasis and acute liver injury.
In Msn+/+ mouse liver collagen deposition and bile duct proliferation
were signiﬁcant around the intra-hepatic bile duct in zone 1 (red stain,Fig. 4. ERM expression in mouse liver. (A–I) Immunoﬂuorescent micrographs of frozen sect
operation. ERM expression was unique in liver tissue: cholangiocytes, ezrin (A–C); bile can
positive cells increased in periductal areas in BDL Msn+/+ mouse liver (H), but ezrin and radix
Msn−/− BDL mouse liver (C and F). Original magniﬁcation, ×200. (J) Immunoblotting. Acute liv
radixin did not change in Msn+/+ and Msn−/− mice. In each lane, 20 μg liver protein from MsFig. 1A and B). Collagen synthesis and proliferation were reduced in
Msn−/− mice (Fig. 1C and D). Focal thermal denaturation produced an
injury with well-deﬁned margins and a reproducible ﬁbrotic response
(Fig. 2A and D). In Msn+/+ liver, the injury focus showed an
inﬂammatory inﬁltrate and angiogenesis, followed by massive
collagen production and ﬁbrosis at the periphery (Fig. 2B and C).
Generally, the injury resolved within 3weeks. In Msn−/− mice, the
inﬂammatory inﬁltrate and ﬁbrosis at the injury margin within the
liver were clearly reduced (Fig. 2E and F). Collagen deposition at the
periphery of the lesion (Fig. 2B and E, black arrow) was quantiﬁed and
found to be 39.3 ± 5.2% of the tissue section in Msn+/+ but only 11.4 ±
3.4% in Msn−/− (Fig. 2G).
BDL and acute liver injuries increased markers of HSC activation,
including expression of α2(I) and α2(I) procollagen, α-SMA and
TGFβ-1mRNAs (Fig. 3). HSC activation and procollagen synthesis were
signiﬁcantly reduced in Msn−/− mice.
3.2. ERM expression in mouse liver
In normal mouse livers, ezrin is expressed in cholangiocytes,
radixin in bile canaliculi in hepatocytes, and moesin in endothelium
or HSCs (Fig. 4A, D and G). BDL did not increase the expression ofions of the livers of Msn+/+ (sham operation or BDL) and Msn−/− (BDL) mice 7 days after
aliculi in hepatocytes, radixin (D–F); and endothelial cells, moesin (G and H). Moesin-
in did not increase (B and E). Expression of ezrin and radixin was not compensatory in
er injuries induced by BDL increased the amount of moesin inMsn+/+ mice, but ezrin and
n+/+ and Msn−/− mice was loaded.
Fig. 5. ERM expression in HSCs. Msn+/+ HSCs were isolated and placed in primary culture for 2 days. Ezrin (A), radixin (B) and moesin (C) are stained green. (D–F) Localization of α-
SMA stained red. (G) Merged images of (A) and (D). (H) Merged images of (B) and (E). (I) Merged images of (C) and (F). In vivo-activated HSCs expressed moesin, but not ezrin or
radixin (A–C). Moesin co-localized with α-SMA at the rufﬂing membrane of HSCs (C, F and I; white arrows). The expression level of moesin was greatest in compact HSCs, which are
migration capable (I; white arrow head). Original magniﬁcation, ×400.
Fig. 6.Migration of HSCs depends on moesin. In vivo-activated HSCs were isolated from
Msn+/+ orMsn−/− mice after common bile duct ligation. HSCs were allowed to spread on
hyaluronic-acid-coated cell culture inserts. The proportion ofMsn+/+ HSCs that migrated
through the ﬁlter averaged 12.5±0.1% at 24 h, and 22.1±1.5% at 36 h. In contract,Msn−/−
HSCs showed essentially no migration at 36 h. Migration index (%)=number of cells on
the bottom surface/sum of cell numbers on upper and bottom surfaces. ⁎Pb0.01.
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Msn+/+mouse livers (Fig. 4B, E and H). Otherwise, ezrin and radixin
did not compensate for moesin deﬁciencies in Msn−/− BDL liver
(Fig. 4C, F and I). Expression of ERM proteins obtained by
immunoblotting was almost consistent with the results of immuno-
ﬂuorescence microscopy. Moesin increased in Msn+/+ BDL liver, but
ezrin/radixin expression did not change in Msn−/− BDL livers (Fig. 4J).
3.3. ERM expression in HSCs
In vivo-activated HSCs expressed moesin but not ezrin or radixin
(Fig. 5A–C). As expected of these linker proteins, moesin co-localized
with α-SMA, notably at the rufﬂing membrane of HSCs (Fig. 5C, F and
I; white arrows). Expression was particularly strong in tall and
compact HSCs, which are the cells with the greatest mobility (Fig. 5I;
white arrow head). The data suggest that linkage of moesin to α-SMA
is essential for the reorganization of the cytoskeleton that occurs with
activation of HSCs.We did not examine the ERMphenotype in culture-
activated HSCs, because our previous study found that these cells lack
migratory capability [2].
3.4. Migratory activity of HSCs
To conﬁrm that activated HSCs from the Msn−/−liver were
migration-impaired, we isolated cells from mouse liver that had
been subjected to total ligation of the biliary duct, an injury that
induces activation of HSCs within 4days. The proportion of Msn+/+
HSCs that migrated through the ﬁlter averaged 12.5 ± 0.1% at 24h, and
22.1 ± 1.5% at 36h. In sharp contrast, Msn−/−HSCs were almost
completely quiescent, with a migration index of only 1.3 ± 1.2% at
36h (Fig. 6). These data provide direct evidence for impairedmigration
of moesin-deﬁcient HSCs.4. Discussion
To the best of our knowledge, this is the ﬁrst report of moesin
being the ERM protein present in HSCs. Previous studies of this family
of proteins in the liver have found that radixin is abundant in
hepatocytes, ezrin in cholangiocytes and moesin in sinusoidal
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several properties with HSCs, express ezrin (and, in culture, radixin),
but not moesin [11]. The counterpart of the HSC in the kidney is the
mesangial cell, which reacts to injury by acquiring myoﬁbroblast-like
properties and producing collagens. It expresses both radixin and
moesin [12]. The predominant linker protein in various types of
ﬁbroblasts in culture is ezrin [13]. We found that repair of the liver
capsule (visceral peritoneum), in contrast to the parenchyma, was
unaffected by moesin deﬁciency. Presumably, the capsule ﬁbroblasts,
which migrate from the abdominal cavity or ascites, utilize ezrin and/
or radixin. We examined the ERM phenotype of mouse embryo
ﬁbroblasts isolated from C57BL/6J mice (E15.5), and found that all
three proteins were expressed (data not shown). Thus, it appears that
expression of moesin alone may be unique to HSCs, just as individual
ERM proteins are unique to other cell types in the liver (see above).
The implications of exclusive expression of a single ERM family
member by a speciﬁc cell type in the liver are speculative. The
function of moesin in HSCs is likely to be similar to that of ERM
proteins generally. These are linker proteins, which when phos-
phorylated are responsible for anchoring the actin cytoskeleton to the
plasma membrane, and are particularly prominent in ﬁlopodia and
microvilli of the plasma membrane [14]. An early facet of the injury
response is migration of HSCs to the affected area. We have
previously shown that HSCs use CD44 for migration on a substratum
of hyaluronic acid [2]. ERM linker proteins are known to form a
complex with CD44 and other migration-related proteins such as
osteopontin [15]. They also likely participate in the formation of focal
contacts between cell and substratum, which provide the traction for
migratory movements. We now report that HSCs without moesin
demonstrated minimal migratory capability.
Fibrogenesis by HSCs accompanies migration, although it is not
clear whether these respective responses to injury are functionally
linked. It is of interest in this regard that ﬁbrogenesis was sharply
attenuated in Msn−/−mice. In our study, moesin deﬁciencies reduced
collagen deposition and bile duct proliferation in zone 1 and HSC
activation. These ﬁndings indicated that moesin speciﬁcally interacts
with membrane-associated proteins, some of which play important
roles in HSC activation and ﬁbrogenesis. It forms a complex with the
beta receptor for platelet-derived growth factor (PDGF-Rβ). The
ligand for this receptor, PDGF, is known to stimulate proliferation,
migration and collagen production by HSCs [16–19]. Another
member of the moesin–PDGF-R complex is sodium–hydrogen
exchanger factor-1, which associates with G-protein-coupled recep-
tors and receptor tyrosine kinase, which mediate intracellular
signaling [20, 21]. Moesin appears to be required for the topogra-
phically and spatially correct formation of this complex. In its
absence, the component proteins may drift within the plasma
membrane and fail to generate the appropriate signals in response
to the ligand, which leads to loss of the activation response. The
expression of TGFβ-1 in Msn−/− control (sham operation) and Msn−/−
BDL mice was signiﬁcantly low. These results suggest that there is
less ﬁbrosis in Msn−/− mouse liver. The mechanism responsible for
low levels of TGFβ-1 is still unclear. In the future, we would like to
investigate actin dynamics and ERM function in HSCs when exposed
to mitogens.
Progression in many chronic liver diseases can be characterized as
inappropriately active or dysregulated repair, and the goal of many
anti-ﬁbrotic strategies is suppressing the repair response. The present
results suggest that interventions that target moesin merit considera-
tion. Despite their altered repair response, Msn−/− mice are phenoty-
pically normal and fertile, which suggests that moesin is not critical
for homeostasis in the adult [7]. In principle, this implies a margin of
safety for agents that compromise moesin function in reactive HSCs,
towards slowing disease progression in chronic liver injury.Acknowledgements
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